Literature DB >> 21519

Incidence and prevalence of endemic benign (epidemic) nephropathy in AC county, Sweden, in relation to population density and prevalence of small rodents.

K Nyström.   

Abstract

Entities:  

Mesh：

Year:  1977        PMID： 21519

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN： 0365-463X


× No keyword cloud information.
  8 in total

1.  Electron Microscopy of Nephropathia Epidemica. Glomerular changes.

Authors:  Y Collan; J Lähdevirta; E J Jokinen
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-02-10

2.  Electron microscopy of nephropathia epidemica. Renal tubular basement membrane.

Authors:  Y Collan; J Lähdevirta; E J Jokinen
Journal:  Am J Pathol       Date:  1978-07       Impact factor: 4.307

3.  Haemorrhagic fever with renal syndrome: Hantaan virus infection.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

4.  Outbreak of haemorrhagic fever with renal syndrome in Greece.

Authors:  K Siamopoulos; A Antoniades; N Acritidis; S Constantopoulos; E Tsianos; I Papapanagiotou; H M Moutsopoulos
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

5.  Experimental infection with Puumala virus, the etiologic agent of nephropathia epidemica, in bank voles (Clethrionomys glareolus).

Authors:  R Yanagihara; H L Amyx; D C Gajdusek
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

6.  Scandinavian epidemic nephropathy and Korean haemorrhagic fever.

Authors:  G Friman; G R French; L Hambraeus; W R Beisel
Journal:  Lancet       Date:  1980-07-12       Impact factor: 79.321

7.  Human hantavirus infections, Sweden.

Authors:  Gert E Olsson; Fredrik Dalerum; Birger Hörnfeldt; Fredrik Elgh; Thomas R Palo; Per Juto; Clas Ahlm
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

8.  Predicting high risk for human hantavirus infections, Sweden.

Authors:  Gert E Olsson; Marika Hjertqvist; Ake Lundkvist; Birger Hörnfeldt
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.